Works about IRINOTECAN
Results: 1763
Examining the Use of Serum Biomarkers to Guide Early Detection of Pancreatic Cancer.
- Published in:
- Clinical Journal of Oncology Nursing, 2025, v. 29, n. 2, p. 151, doi. 10.1188/25.CJON.151-156
- By:
- Publication type:
- Article
Quality of Life in Patients with Locally Advanced Pancreatic Cancer During Stereotactic Radiotherapy Combined with Heat-Killed Mycobacterium Obuense Vaccination.
- Published in:
- Journal of Palliative Medicine, 2025, v. 28, n. 3, p. 351, doi. 10.1089/jpm.2024.0160
- By:
- Publication type:
- Article
Efficacy and safety of triplet regimen capecitabine, oxaliplatin, and irinotecan (XELOXIRI) as first-line chemotherapy for advanced pancreatic cancer.
- Published in:
- BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-13799-5
- By:
- Publication type:
- Article
Correction: Efficacy of liposomal irinotecan + 5-FU/LV vs. S-1 in gemcitabine-refractory metastatic pancreatic cancer: a real-world study using inverse probability of treatment weighting.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
In situ valence-transited arsenic nanosheets for multi-modal therapy of colorectal cancer.
- Published in:
- Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-57376-7
- By:
- Publication type:
- Article
Screening of common genomic biomarkers to explore common drugs for the treatment of pancreatic and kidney cancers with type-2 diabetes through bioinformatics analysis.
- Published in:
- Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-91875-3
- By:
- Publication type:
- Article
Understanding the Toxicity Profile of Approved ADCs.
- Published in:
- Pharmaceutics, 2025, v. 17, n. 2, p. 258, doi. 10.3390/pharmaceutics17020258
- By:
- Publication type:
- Article
Correction: Maksymowicz et al. The Use of Endo-Cellulase and Endo-Xylanase for the Extraction of Apple Pectins as Factors Modifying Their Anticancer Properties and Affecting Their Synergy with the Active Form of Irinotecan. Pharmaceuticals 2022, 15 , 732.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Melanocortin-4 Receptor Antagonism Inhibits Colorectal and Anaplastic Thyroid Cancer In Vitro and In Vivo.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1165, doi. 10.3390/jcm14041165
- By:
- Publication type:
- Article
Retrospective evaluation of toceranib phosphate (Palladia) in the treatment of canine carcinomatosis and mesothelioma.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Increased incidence of gastrointestinal toxicity in canine cancer patients treated with concurrent abdominal radiation therapy and toceranib phosphate.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 142, doi. 10.1111/vco.12756
- By:
- Publication type:
- Article
Tapcin, an In Vivo Active Dual Topoisomerase I/II Inhibitor Discovered by Synthetic Bioinformatic Natural Product (Syn‐BNP)‐Coupled Metagenomics.
- Published in:
- Angewandte Chemie, 2024, v. 136, n. 17, p. 1, doi. 10.1002/ange.202317187
- By:
- Publication type:
- Article
Contribution and limits of a non-intrusive Raman spectroscopic method compared with HPLC for routine application to pre-delivery analytical control of two major camptothecin analogs: irinotecan and topotecan.
- Published in:
- Journal of Raman Spectroscopy, 2015, v. 46, n. 12, p. 1283, doi. 10.1002/jrs.4761
- By:
- Publication type:
- Article
A rapid ex vivo tissue model for optimising drug detection and ionisation in MALDI imaging studies.
- Published in:
- Histochemistry & Cell Biology, 2014, v. 142, n. 4, p. 361, doi. 10.1007/s00418-014-1223-0
- By:
- Publication type:
- Article
Pharmacophore and 3d-Qsar Modeling of new 1,3,4-Thiadiazole Derivatives: Specificity to Colorectal Cancer.
- Published in:
- Pharmaceutical Chemistry Journal, 2020, v. 54, n. 1, p. 12, doi. 10.1007/s11094-020-02149-3
- By:
- Publication type:
- Article
Preparation irinotecan hydrochloride loaded PEGylated liposomes using novel method supercritical fluid and condition optimized by Box–Behnken design.
- Published in:
- Discover Nano, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s11671-024-04071-z
- By:
- Publication type:
- Article
Second-line Therapy after Trastuzumab Failure in HER2-Positive Metastatic Gastric Cancer: A Real-life Data.
- Published in:
- Eurasian Journal of Medical Investigation, 2023, v. 7, n. 2, p. 153, doi. 10.14744/ejmi.2023.22720
- By:
- Publication type:
- Article
Personalized dose selection platform for patients with solid tumors in the PRECISE CURATE.AI feasibility trial.
- Published in:
- NPJ Precision Oncology, 2025, v. 9, n. 1, p. 1, doi. 10.1038/s41698-025-00835-7
- By:
- Publication type:
- Article
Ischemic Colitis of the Transverse Colon Induced by 5-Fluorouracil, Leucovorin, and Irinotecan: A Case Report.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Pharmacogenetics of irinotecan, doxorubicin and docetaxel transporters in Asian and Caucasian cancer patients: a comparative review.
- Published in:
- Drug Metabolism Reviews, 2016, v. 48, n. 4, p. 502, doi. 10.1080/03602532.2016.1226896
- By:
- Publication type:
- Article
Synthesis and characterization of magnetic nanocomposite for in vitro evaluation of irinotecan using human cell lines.
- Published in:
- Turkish Journal of Chemistry, 2021, v. 45, n. 3, p. 540, doi. 10.3906/kim-2010-53
- By:
- Publication type:
- Article
Brain derived neurotrophic factor declines after complete curative resection in gastrointestinal cancer.
- Published in:
- PeerJ, 2021, p. 1, doi. 10.7717/peerj.11718
- By:
- Publication type:
- Article
In vitro anticancer activity of methanolic extract of Granulocystopsis sp., a microalgae from an oligotrophic oasis in the Chihuahuan desert.
- Published in:
- PeerJ, 2020, p. 1, doi. 10.7717/peerj.8686
- By:
- Publication type:
- Article
Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 8, p. 1, doi. 10.1093/jnci/djv132
- By:
- Publication type:
- Article
Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 8, p. 1, doi. 10.1093/jnci/djv132
- By:
- Publication type:
- Article
Synthesis, DFT calculations, and anti-proliferative evaluation of pyrimidine and selenadiazolopyrimidine derivatives as dual Topoisomerase II and HSP90 inhibitors.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2023, v. 38, n. 1, p. 1, doi. 10.1080/14756366.2023.2198163
- By:
- Publication type:
- Article
Investigating the potential anticancer activities of antibiotics as topoisomerase II inhibitors and DNA intercalators: in vitro, molecular docking, molecular dynamics, and SAR studies.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2023, v. 38, n. 1, p. 1, doi. 10.1080/14756366.2023.2171029
- By:
- Publication type:
- Article
Design and synthesis of novel rigid dibenzo[b,f]azepines through ring closure technique as promising anticancer candidates against leukaemia and acting as selective topoisomerase II inhibitors and DNA intercalators.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2023, v. 38, n. 1, p. 1, doi. 10.1080/14756366.2022.2157825
- By:
- Publication type:
- Article
Discovery of novel conjugates of quinoline and thiazolidinone urea as potential anti-colorectal cancer agent.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2022, v. 37, n. 1, p. 2334, doi. 10.1080/14756366.2022.2117318
- By:
- Publication type:
- Article
The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2019, v. 34, n. 1, p. 117, doi. 10.1080/14756366.2018.1532419
- By:
- Publication type:
- Article
Author Correction: Reprogramming of palmitic acid induced by dephosphorylation of ACOX1 promotes β-catenin palmitoylation to drive colorectal cancer progression.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Reprogramming of palmitic acid induced by dephosphorylation of ACOX1 promotes β-catenin palmitoylation to drive colorectal cancer progression.
- Published in:
- Cell Discovery, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41421-022-00515-x
- By:
- Publication type:
- Article
Determination of the Camptothecin Derivatives CPT-11 and SN-38 in Urine and Saliva by Micellar Electrokinectic Chromatography.
- Published in:
- Analytical Letters, 2012, v. 45, n. 13, p. 1849, doi. 10.1080/00032719.2012.677985
- By:
- Publication type:
- Article
INVESTIGATION OF PROTECTIVE EFFECTS OF FULLERENOL in vivo IN CHRONIC NEPHROPATHY DURING DOXORUBICIN THERAPY OF MALIGN NEOPLASM IN RATS.
- Published in:
- Oxidation Communications, 2024, v. 47, n. 1, p. 10
- By:
- Publication type:
- Article
A Mathematical Model to Optimize the Neoadjuvant Chemotherapy Treatment Sequence for Triple-Negative Locally Advanced Breast Cancer.
- Published in:
- Mathematics (2227-7390), 2023, v. 11, n. 11, p. 2410, doi. 10.3390/math11112410
- By:
- Publication type:
- Article
Effectiveness of l-carnitine Nanoparticles against Nephrotoxicity Induced by 5- Fluorouracil in Ehrlich ascites Carcinoma Bearing Mice.
- Published in:
- Egyptian Academic Journal of Biological Sciences. B, Zoology, 2024, v. 16, n. 1, p. 31, doi. 10.21608/EAJBSZ.2024.340550
- By:
- Publication type:
- Article
RAS and Colon Cancer: What You're Missing.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 5, p. 264
- By:
- Publication type:
- Article
Very low blood flow carbon dioxide removal system is not effective in a chronic obstructive pulmonary disease exacerbation setting.
- Published in:
- Artificial Organs, 2021, v. 45, n. 5, p. 479, doi. 10.1111/aor.13867
- By:
- Publication type:
- Article
EGFR-targeting polydopamine nanoparticles co-loaded with 5-fluorouracil, irinotecan, and leucovorin to potentially enhance metastatic colorectal cancer therapy.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-80879-0
- By:
- Publication type:
- Article
Longitudinal dynamics of circulating tumor DNA for treatment monitoring in patients with breast cancer recurrence.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-70887-5
- By:
- Publication type:
- Article
Generation of novel lipid metabolism-based signatures to predict prognosis and immunotherapy response for colorectal adenocarcinoma.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-67549-x
- By:
- Publication type:
- Article
Nanoliposomal irinotecan with fluorouracil and folinic acid, FOLFIRINOX, and S-1 as second-line treatment for unresectable pancreatic cancer after gemcitabine/nab-paclitaxel.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-65689-8
- By:
- Publication type:
- Article
A multicenter retrospective observational NAPOLEON2 study of nanoliposomal irinotecan with fluorouracil and folinic acid in patients with unresectable pancreatic cancer.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-63172-y
- By:
- Publication type:
- Article
In Silico Study of Camptothecin-Based Pro-Drugs Binding to Human Carboxylesterase 2.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 2, p. 153, doi. 10.3390/biom14020153
- By:
- Publication type:
- Article
Novel Set of Diarylmethanes to Target Colorectal Cancer: Synthesis, In Vitro and In Silico Studies.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 1, p. 54, doi. 10.3390/biom13010054
- By:
- Publication type:
- Article
Proinflammatory and Cancer-Promoting Pathobiont Fusobacterium nucleatum Directly Targets Colorectal Cancer Stem Cells.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 9, p. 1256, doi. 10.3390/biom12091256
- By:
- Publication type:
- Article
Target-Based Small Molecule Drug Discovery for Colorectal Cancer: A Review of Molecular Pathways and In Silico Studies.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 7, p. N.PAG, doi. 10.3390/biom12070878
- By:
- Publication type:
- Article
The Analysis of NADPH Quinone Reductase 1 (NQO1) Polymorphism in Polish Patients with Colorectal Cancer.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 7, p. 1024, doi. 10.3390/biom11071024
- By:
- Publication type:
- Article
High NRF2 Levels Correlate with Poor Prognosis in Colorectal Cancer Patients and with Sensitivity to the Kinase Inhibitor AT9283 In Vitro.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 10, p. 1365, doi. 10.3390/biom10101365
- By:
- Publication type:
- Article
Lichen Secondary Metabolite Physciosporin Decreases the Stemness Potential of Colorectal Cancer Cells.
- Published in:
- Biomolecules (2218-273X), 2019, v. 9, n. 12, p. 797, doi. 10.3390/biom9120797
- By:
- Publication type:
- Article